CIK: 1396943 - Address: C/o Kezar Life Sciences, Inc., 4000 Shoreline Court, Suite 300, South San Francisco, CA 94080
16 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret115-1-3-15-32-50-32-22
S%wins808010010010010093

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

7/8/21 18:00
7/6/21
BEAMBeam Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagCooper Graham KMADM.d4417.00030D
7/8/21 18:00
7/6/21
BEAMBeam Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagCooper Graham KMADS.d-315120.610-3-1000D
6/30/21 18:00
6/28/21
BEAMBeam Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagCooper Graham KMADM.d20517.000120D
6/30/21 18:00
6/28/21
BEAMBeam Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagCooper Graham KMADS.d-1,281106.340-12-1000D
2/26/21 18:59
2/10/21
NUVBNuvation Bio Inc.DEHealthDrugPharmaceutical PreparationsCooper Graham KCADM.d00.00025New25D
9/17/14 20:58
9/16/14
RCPTReceptos, Inc.DEHealthDrugPharmaceutical PreparationsCooper Graham KCAOCFOM.d2555.100500D
9/17/14 20:58
9/16/14
RCPTReceptos, Inc.DEHealthDrugPharmaceutical PreparationsCooper Graham KCAOCFOS.d-3,06561.300-50-1000D
12/23/09 18:07
12/21/09
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooper Graham KCAOCFO,TreaS-1478.390-18-1000D-397286-1227192317-2-9-20-24-49-2
12/23/09 18:06
12/21/09
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooper Graham KCAOCFO,TreaM.d700.7000010018D-397286-1227192317-2-9-20-24-49-2
12/23/09 18:06
12/21/09
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooper Graham KCAOCFO,TreaS.d-6788.220-83-8318D-397286-1227192317-2-9-20-24-49-2
8/25/08 21:36
8/21/08
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooper Graham KCAOCFO,TreaM.d60.7000080D-15-24757291213-3-2-11-62-62-32
8/25/08 21:36
8/21/08
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooper Graham KCAOCFO,TreaS.d-9912.000-8-1000D-15-24757291213-3-2-11-62-62-32
12/21/07 17:51
12/20/07
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooper Graham KCAOCFO,TreaM.d30.7000040D0-1-584-133-22-28-44-65
12/21/07 17:51
12/20/07
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooper Graham KCAOCFO,TreaS.d-5614.090-4-1000D0-1-584-133-22-28-44-65
11/21/07 16:39
11/20/07
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooper Graham KCAOCFO,TreaM.d30.7000040D-187-162-1-400-2-21-47-61
11/21/07 16:39
11/20/07
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCooper Graham KCAOCFO,TreaS.d-5914.740-4-1000D-187-162-1-400-2-21-47-61

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact